obesity drug glp-1 news today New oral delivers up to 12% weight loss in 36 weeks Market Overview: GLP-1 Agonists and
Description
Key Takeaways Retatrutide activates GLP-1R, GIPR, and GCGR simultaneously, making it structurally distinct from both semaglutide (GLP-1 only) and tirzepatide (GLP-1 and GIP only)
Note: Prices can vary depending on the pharmacy, location, and dosage
Similar content being viewed by others Background Incretin hormones are peptides released in the intestine in response to the presence of nutrients in its lumen
FDA Crackdown on Compounded GLP-1s (Regulatory): On February 6, 2026, the FDA announced a formal intent to restrict the use of active pharmaceutical ingredients (APIs) for non-approved compounded GLP-1 drugs, targeting "mass-marketed" alternatives from companies like Hims & Hers as the national supply of brand-name versions stabilized
Notice something
*Correspondence: Guobing Chen, [email protected]
